OBJECTIVE: Apolipoprotein E (apoE), a key protein in lipid metabolism, is highly expressed in adipose tissues. Studies have shown that human APOE*4 is associated with a lower body mass index but with a greater risk of coronary heart disease compared with other APOE alleles. To define the isoform-specific role of apoE in regulating the expandability and functionality of adipose tissues, we investigated the effects of diet-induced obesity in mice whose endogenous Apoe gene has been replaced by either the human APOE*3 or APOE*4 allele. RESULTS: After 8 weeks on a Western-type high-fat diet, male APOE4 mice displayed impaired tolerance to glucose and fat overload compared with APOE3 mice. Subcutaneous fat tissues in APOE4 and APOE3 mice after high fat feeding were not different. In contrast, although epididymal fat tissues in APOE4 mice gained 30% less weight during the high fat feeding than in APOE3 mice, they showed impaired insulin-stimulated glucose uptake ex vivo. Epididymal APOE4 adipocytes were larger in size than APOE3 adipocytes, and expressed reduced levels of mRNA for peroxisome proliferator-activated receptor gamma2 and adiponectin, important markers of adipocyte functionality. Adenoviral expression of apoE3 in apoE-null culture adipocytes induced adiponectin mRNA in a dose-dependent manner, but the induction was significantly blunted in cells overexpressing apoE4. However, in contrast to the apoE3-expressing cells, Glut1, but not Glut4, expression levels were positively correlated with increased apoE4 mRNA, suggesting that apoE4 expression in adipocyte interferes in insulin-sensing pathways. CONCLUSION: Dysfunctional epididymal adipose tissues contribute to the accelerated impairment of glucose tolerance in APOE4 mice fed a Western-type diet. Our results underscore the importance of functionality of individual fat depots rather than total fat mass as a determinant for metabolic disturbance during diet-induced obesity.
OBJECTIVE:Apolipoprotein E (apoE), a key protein in lipid metabolism, is highly expressed in adipose tissues. Studies have shown that humanAPOE*4 is associated with a lower body mass index but with a greater risk of coronary heart disease compared with other APOE alleles. To define the isoform-specific role of apoE in regulating the expandability and functionality of adipose tissues, we investigated the effects of diet-induced obesity in mice whose endogenous Apoe gene has been replaced by either the humanAPOE*3 or APOE*4 allele. RESULTS: After 8 weeks on a Western-type high-fat diet, male APOE4mice displayed impaired tolerance to glucose and fat overload compared with APOE3mice. Subcutaneous fat tissues in APOE4 and APOE3mice after high fat feeding were not different. In contrast, although epididymal fat tissues in APOE4mice gained 30% less weight during the high fat feeding than in APOE3mice, they showed impaired insulin-stimulated glucose uptake ex vivo. Epididymal APOE4 adipocytes were larger in size than APOE3 adipocytes, and expressed reduced levels of mRNA for peroxisome proliferator-activated receptor gamma2 and adiponectin, important markers of adipocyte functionality. Adenoviral expression of apoE3 in apoE-null culture adipocytes induced adiponectin mRNA in a dose-dependent manner, but the induction was significantly blunted in cells overexpressing apoE4. However, in contrast to the apoE3-expressing cells, Glut1, but not Glut4, expression levels were positively correlated with increased apoE4 mRNA, suggesting that apoE4 expression in adipocyte interferes in insulin-sensing pathways. CONCLUSION:Dysfunctional epididymal adipose tissues contribute to the accelerated impairment of glucose tolerance in APOE4mice fed a Western-type diet. Our results underscore the importance of functionality of individual fat depots rather than total fat mass as a determinant for metabolic disturbance during diet-induced obesity.
Authors: J B Meigs; J M Ordovas; L A Cupples; D E Singer; D M Nathan; E J Schaefer; P W Wilson Journal: Diabetes Care Date: 2000-05 Impact factor: 19.112
Authors: Mary F Feitosa; Treva Rice; Kari E North; Aldi Kraja; Tuomo Rankinen; Arthur S Leon; James S Skinner; John Blangero; Claude Bouchard; D C Rao Journal: Atherosclerosis Date: 2005-07-25 Impact factor: 5.162
Authors: Angelo Scuteri; Samer S Najjar; Denis Muller; Reubin Andres; Christopher H Morrell; Alan B Zonderman; Edward G Lakatta Journal: Am J Physiol Endocrinol Metab Date: 2005-03-15 Impact factor: 4.310
Authors: Kelly A Volcik; Ruth Ann Barkley; Richard G Hutchinson; Thomas H Mosley; Gerardo Heiss; A Richey Sharrett; Christie M Ballantyne; Eric Boerwinkle Journal: Am J Epidemiol Date: 2006-06-07 Impact factor: 4.897
Authors: José M Arbonés-Mainar; María A Navarro; Sergio Acín; Mario A Guzmán; Carmen Arnal; Joaquín C Surra; Ricardo Carnicer; Helen M Roche; Jesús Osada Journal: J Nutr Date: 2006-02 Impact factor: 4.798
Authors: Jose M Arbones-Mainar; Lance A Johnson; Michael K Altenburg; Hyung-Suk Kim; Nobuyo Maeda Journal: FASEB J Date: 2010-05-25 Impact factor: 5.191
Authors: James G Cash; David G Kuhel; Joshua E Basford; Anja Jaeschke; Tapan K Chatterjee; Neal L Weintraub; David Y Hui Journal: J Biol Chem Date: 2012-06-23 Impact factor: 5.157
Authors: Lance A Johnson; Reid H J Olsen; Louise S Merkens; Andrea DeBarber; Robert D Steiner; Patrick M Sullivan; Nobuyo Maeda; Jacob Raber Journal: Neurobiol Dis Date: 2014-01-09 Impact factor: 5.996
Authors: J M Arbones-Mainar; L A Johnson; E Torres-Perez; A E Garcia; S Perez-Diaz; J Raber; N Maeda Journal: Int J Obes (Lond) Date: 2016-05-10 Impact factor: 5.095
Authors: Sergio Perez-Diaz; Lance A Johnson; Robert M DeKroon; Jose M Moreno-Navarrete; Oscar Alzate; Jose M Fernandez-Real; Nobuyo Maeda; Jose M Arbones-Mainar Journal: FASEB J Date: 2014-05-08 Impact factor: 5.191